Open AccessDapagliflozin Improves Glycemic Control and Reduces Body Weight as Add-on Therapy to Metformin Plus Sulfonylurea: A 24-Week Randomized, Double-Blind Clinical Trial
Author(s) -
S. Matthäei,
Keith Bowering,
Katja Rohwedder,
A Grohl,
Shamik Parikh
Publication year - 2015
Publication title -
diabetes care
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.636
H-Index - 363
eISSN - 1935-5548
pISSN - 0149-5992
DOI - 10.2337/dc14-0666
Subject(s) - dapagliflozin , metformin , sulfonylurea , medicine , placebo , glycemic , endocrinology , type 2 diabetes , diabetes mellitus , insulin , urology , gastroenterology , alternative medicine , pathology
To evaluate the efficacy and safety of dapagliflozin in patients with type 2 diabetes inadequately controlled with metformin and sulfonylurea.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom